Efficacy and safety of the suppository of Recombinant Streptokinase in the hemorrhoidal acute disease

Trial Profile

Efficacy and safety of the suppository of Recombinant Streptokinase in the hemorrhoidal acute disease

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Mar 2017

At a glance

  • Drugs Streptokinase (Primary)
  • Indications Haemorrhoids; Thrombosis
  • Focus Therapeutic Use
  • Acronyms THERESA-2
  • Most Recent Events

    • 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
    • 08 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top